Immunocore Holdings (IMCR) Cash & Equivalents (2018 - 2026)
Immunocore Holdings (IMCR) posted Cash & Equivalents of $484.92 million for Q2 2026, down 0.6% from $487.93 million a year earlier but up 7.1% from the prior quarter.
Powered by 
Analysis
Immunocore Holdings (IMCR) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Immunocore Holdings' Cash & Equivalents came in at $467.71 million, up 2.6% from FY2024.
- Annual Cash & Equivalents has increased for six consecutive years, with a five-year compound annual growth rate of 22.3% (FY2020 to FY2025).
- In prior years, Immunocore Holdings' Cash & Equivalents was $455.73 million in FY2024 (+3.0%), $442.63 million in FY2023 (+10.0%), $402.47 million in FY2022 (+23.0%) and $327.3 million in FY2021 (+91.1%).
- Quarterly Cash & Equivalents has run from a low of $262.02 million in Q2 2022 to a high of $832.82 million in Q1 2024 over five years.
- On a year-over-year basis, Cash & Equivalents increased in two of the last seven quarters, with an average decline of 7.6%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2021, with growth of 87.2%; the weakest was Q1 2025, with a decline of 42.7%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $452.68 million (Q1 2026), $467.71 million (Q4 2025) and $498.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Immunocore Holdings | 1.67 Bn | -1.82 Bn | 101.55 Mn | 512.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 512.25 Mn |
| Jun 30, 2026 | 484.92 Mn |
| Mar 31, 2026 | 452.68 Mn |
| Dec 31, 2025 | 467.71 Mn |
| Sep 30, 2025 | 498.41 Mn |
| Jun 30, 2025 | 487.93 Mn |
| Mar 31, 2025 | 476.85 Mn |
| Dec 31, 2024 | 455.73 Mn |
| Sep 30, 2024 | 537.77 Mn |
| Jun 30, 2024 | 504.99 Mn |
| Mar 31, 2024 | 832.82 Mn |
| Dec 31, 2023 | 442.63 Mn |
| Sep 30, 2023 | 444.20 Mn |
| Jun 30, 2023 | 431.85 Mn |
| Mar 31, 2023 | 418.02 Mn |
| Dec 31, 2022 | 400.92 Mn |
| Sep 30, 2022 | 387.79 Mn |
| Jun 30, 2022 | 252.42 Mn |
| Mar 31, 2022 | 270.47 Mn |
| Dec 31, 2021 | 321.11 Mn |
API Access
Immunocore Holdings Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();